Sanofi India shares traded in negative territory on April 22, 2026, as the stock turned ex-dividend for a final dividend of Rs 48 per share. The company had announced the dividend earlier this month, with the record date set for April 23.
Dividend Details
The board of Sanofi India had declared a final dividend of Rs 48 per equity share of face value Rs 10 each for the financial year 2025-26. The dividend is subject to deduction of tax at source as applicable. The total dividend payout is expected to be around Rs 220 crore.
Stock Performance
On the ex-date, Sanofi India shares opened lower and continued to trade in the red. The stock was down over 1% in early trade on the BSE. The ex-dividend adjustment typically leads to a drop in share price equivalent to the dividend amount, as the company's retained earnings decrease.
Record Date
The company has fixed April 23 as the record date for determining the eligibility of shareholders for the final dividend. Investors holding shares as of the record date will be entitled to the dividend. The dividend will be paid within 30 days from the date of declaration.
Company Background
Sanofi India is a subsidiary of the French pharmaceutical giant Sanofi. The company is engaged in the manufacturing and marketing of pharmaceutical products in India. It has a strong presence in the areas of diabetes, cardiovascular diseases, and consumer healthcare.
Financial Performance
For the financial year 2025-26, Sanofi India reported a net profit of Rs 850 crore, up from Rs 780 crore in the previous year. Revenue from operations stood at Rs 5,200 crore, reflecting a growth of 8% year-on-year. The company's strong performance was driven by increased demand for its key products and cost optimization measures.
Market Outlook
Analysts remain positive on Sanofi India's growth prospects, citing its robust product pipeline and strong brand equity. However, they caution that the stock may remain under pressure in the near term due to the ex-dividend adjustment. The company's focus on innovation and expansion in the Indian market is expected to drive long-term value for shareholders.
Investors are advised to consult their financial advisors before making any investment decisions.
